Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Cardiology · Non-ST-Elevation Acute Coronary Syndrome

Determining Your Risk: The GRACE Score and Treatment Timing

At a Glance

For NSTE-ACS, the GRACE score combines age, vital signs, kidney function, heart findings, ECG changes, and troponin to estimate risk. A higher or unstable risk profile generally calls for faster coronary angiography, while stable lower-risk cases may be assessed selectively.

When you are hospitalized for NSTE-ACS, one of the most important tasks your medical team performs is risk stratification [1]. This isn’t just a paperwork exercise; it is a precise way of estimating your clinical risk to help decide how fast you need an “invasive strategy” (an angiogram to look at your heart’s arteries) [2].

The GRACE Score: Estimating Your Risk

Doctors often use tools like the GRACE score (Global Registry of Acute Cardiac Events) to calculate your risk level [3]. This score takes several pieces of information about you and turns them into a number that helps predict how your heart will behave over the next few months [4][5].

The score considers these eight variables:

  1. Age: Risk naturally increases as we get older [3].
  2. Heart Rate: A very fast heart rate can signal the heart is under stress [3].
  3. Systolic Blood Pressure: Very low blood pressure can be a sign of instability [3].
  4. Kidney Function: Measured by your creatinine levels; the heart and kidneys are closely linked [3].
  5. Killip Class: A physical exam finding that checks for signs of heart failure, like fluid in the lungs [3].
  6. Cardiac Arrest: Whether your heart stopped at any point during this event [3].
  7. ST-Segment Changes: Specific patterns on your EKG that show the heart is struggling for oxygen [3].
  8. Elevated Troponin: Whether your blood tests confirm heart muscle injury [3].

The Timing: Guideline Goals

Based on your clinical stability, the GRACE score, and your physical symptoms, you will be placed into a “timing” category for your angiogram. Modern guidelines (including the 2023 ESC and 2025 AHA/ACC updates) offer goals emphasizing that the more unstable you are, the faster you must be treated, though exact timing depends on local resources and your overall health [1][6].

Risk Category Clinical Criteria Treatment Timing Goal
Very High Risk Ongoing chest pain that won’t stop, life-threatening heart rhythms, shock, or severe heart failure [2][7]. Immediate (< 2 hours): Usually treated as an absolute emergency [1].
High Risk A GRACE score over 140, confirmed NSTEMI, or clear EKG changes [8][9]. Early (< 24 hours): Treated promptly within the first day of admission [1].
Low/Intermediate Stable symptoms, GRACE score under 140, and no high-risk signs [10][11]. Selective: May have non-invasive imaging or a delayed angiogram (up to 72 hours) [10][12].

Why Doctors Wait for Some Patients

It may seem counterintuitive to wait up to 24 hours if you’ve had a heart event. However, for patients who are stable (High Risk but not Very High Risk), taking a few hours to start antithrombotic medications and stabilize the body can actually make the eventual procedure safer [13][14].

Research has shown that for those with a high GRACE score, getting to the lab early can reduce the chance of recurrent ischemia [15][14]. Conversely, for those with a low risk, rushing into a procedure doesn’t always provide a benefit and may even increase the risk of bleeding or other complications [16][10]. In selected suspected or low-risk ACS cases (but generally not for confirmed NSTEMI), your doctor may choose a non-invasive approach first, such as a Coronary CT Angiography (CCTA), to safely view the arteries [17].

Your position on this timeline is a dynamic decision. If you are waiting for a procedure and your pain suddenly returns or becomes severe, your team will immediately reassess you and may move you into an emergency category. Be sure to alert the staff immediately if symptoms return [2].

Common questions in this guide

What is the GRACE score for NSTE-ACS?
The GRACE score is a clinical risk calculator used for people with non-ST-elevation acute coronary syndrome. It combines age, heart rate, blood pressure, kidney function, heart failure findings, cardiac arrest, ECG changes, and troponin to estimate risk and help guide how quickly coronary angiography should be performed.
What does a GRACE score above 140 mean?
A GRACE score above 140 places a patient in a high-risk category in this treatment framework. If the patient is otherwise stable, clinicians generally aim for an early invasive evaluation, often coronary angiography within 24 hours, while adjusting for symptoms, overall health, and local resources.
When is an angiogram needed immediately for NSTE-ACS?
Immediate evaluation, with a goal of within about two hours, is considered for very-high-risk features such as ongoing or returning chest pain, shock, life-threatening heart rhythms, or severe heart failure. The treating team may change the timing quickly if a patient's condition worsens.
Why might doctors wait before doing an angiogram?
For a stable patient who is high risk but not very high risk, a short delay can allow antithrombotic treatment and stabilization before the procedure. In lower-risk cases, rushing to an invasive procedure may not add benefit and can increase bleeding or other complications.
How do kidney function and blood pressure affect my GRACE score?
The GRACE score includes creatinine, a blood test used to assess kidney function, and systolic blood pressure. Reduced kidney function or very low blood pressure can increase estimated risk and may affect both the urgency of angiography and how treatment is planned.
Can a CT scan replace an angiogram in suspected acute coronary syndrome?
In selected people with suspected or low-risk acute coronary syndrome, coronary CT angiography may be used as a non-invasive way to view the coronary arteries. It is generally not the preferred first approach for confirmed NSTEMI, so the choice depends on the diagnosis, risk level, symptoms, and local expertise.
What should I do if chest pain returns while I am waiting for angiography?
Tell the nurse or medical team immediately if chest pressure, pain, shortness of breath, or other symptoms return or become more severe. The team will reassess you and may move you to an emergency treatment category.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my risk score (like the GRACE score), and how is it guiding my treatment timeline?
  2. 2.Do I have any 'very-high-risk' features, like ongoing pain or heart failure signs, that require a procedure within the next two hours?
  3. 3.How are my kidney function and blood pressure levels affecting my risk score and the choice of when to perform an angiogram?
  4. 4.If I am in the 'delayed' or 'selective' group, what symptoms should I watch for that would move me into a higher urgency category?
  5. 5.Is non-invasive imaging, like a CT scan, being considered for my specific situation?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Immediate and early percutaneous coronary intervention in very high-risk and high-risk non-ST segment elevation myocardial infarction patients.

    Lupu L, Taha L, Banai A, et al.

    Clinical cardiology 2022; (45(4)):359-369 doi:10.1002/clc.23781.

    PMID: 35266561
  2. 2

    Clinical outcomes of invasive versus conservative strategies for very high-risk patients with non-ST-elevation acute coronary syndrome: an observational cohort study in a real-world population of China.

    Liu Y, Zeng L, Yu S, et al.

    EClinicalMedicine 2026; (97()):104071 doi:10.1016/j.eclinm.2026.104071.

    PMID: 42518941
  3. 3

    Validity of the updated GRACE risk predictor (version 2.0) in patients with non-ST-elevation acute coronary syndrome.

    Akyuz S, Yazici S, Bozbeyoglu E, et al.

    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 2016; (35(1)):25-31.

    PMID: 26718493
  4. 4

    Prognostic value of GRACE score for in-hospital and 6 months outcomes after non-ST elevation acute coronary syndrome.

    Kumar D, Ashok A, Saghir T, et al.

    The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology 2021; (73(1)):22 doi:10.1186/s43044-021-00146-9.

    PMID: 33677742
  5. 5

    External validation of the GRACE risk score and the risk-treatment paradox in patients with acute coronary syndrome.

    van der Sangen NMR, Azzahhafi J, Chan Pin Yin DRPP, et al.

    Open heart 2022; (9(1)) doi:10.1136/openhrt-2022-001984.

    PMID: 35354660
  6. 6

    2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

    Rao SV, O'Donoghue ML, Ruel M, et al.

    Circulation 2025; (151(13)):e771-e862 doi:10.1161/CIR.0000000000001309.

    PMID: 40014670
  7. 7

    Immediate versus delayed coronary angiography in patients with non-ST segment elevation acute coronary syndrome complicated with acute decompensated heart failure: The EARLY-HF randomized clinical trial.

    Lim Y, Park S, Joo D, et al.

    Cardiovascular revascularization medicine : including molecular interventions 2026; (83()):32-39 doi:10.1016/j.carrev.2025.09.016.

    PMID: 41073186
  8. 8

    Timing of coronary angiography and use of antiplatelet pretreatment in patients with NSTEACS in Spain.

    Díez-Delhoyo F, López Lluva MT, Cepas-Guillén P, et al.

    Revista espanola de cardiologia (English ed.) 2024; (77(3)):234-242 doi:10.1016/j.rec.2023.07.013.

    PMID: 38476000
  9. 9

    Prehospital risk assessment in patients suspected of non-ST-segment elevation acute coronary syndrome: a systematic review and meta-analysis.

    Demandt JPA, Zelis JM, Koks A, et al.

    BMJ open 2022; (12(4)):e057305 doi:10.1136/bmjopen-2021-057305.

    PMID: 35383078
  10. 10

    Routine invasive versus selective invasive strategies for Non-ST-elevation acute coronary syndromes: An Updated meta-analysis of randomized trials.

    Elgendy IY, Kumbhani DJ, Mahmoud AN, et al.

    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2016; (88(5)):765-774 doi:10.1002/ccd.26679.

    PMID: 27515910
  11. 11

    Pre-hospital risk assessment in suspected non-ST-elevation acute coronary syndrome: A prospective observational study.

    van Dongen DN, Tolsma RT, Fokkert MJ, et al.

    European heart journal. Acute cardiovascular care 2020; (9(1_suppl)):5-12 doi:10.1177/2048872618813846.

    PMID: 30468395
  12. 12

    Coronary computed tomography angiography improves assessment of patients with acute chest pain and inconclusively elevated high-sensitivity troponins.

    Arslan M, Schaap J, van Gorsel B, et al.

    European radiology 2025; (35(2)):789-797 doi:10.1007/s00330-024-10930-1.

    PMID: 39150488
  13. 13

    Indications for an early invasive strategy in NSTE-ACS patients.

    Zwart B, Ten Berg JM, van 't Hof AW, et al.

    Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2020; (28(3)):131-135 doi:10.1007/s12471-019-01337-5.

    PMID: 31696408
  14. 14

    Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.

    Kofoed KF, Kelbæk H, Hansen PR, et al.

    Circulation 2018; (138(24)):2741-2750 doi:10.1161/CIRCULATIONAHA.118.037152.

    PMID: 30565996
  15. 15

    Meta-analysis of optimal timing of coronary intervention in non-ST-elevation acute coronary syndrome.

    Barbarawi M, Kheiri B, Zayed Y, et al.

    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2020; (95(2)):185-193 doi:10.1002/ccd.28280.

    PMID: 31111670
  16. 16

    Importance of Risk Assessment in Timing of Invasive Coronary Evaluation and Treatment of Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome: Insights From the VERDICT Trial.

    Butt JH, Kofoed KF, Kelbæk H, et al.

    Journal of the American Heart Association 2021; (10(19)):e022333 doi:10.1161/JAHA.121.022333.

    PMID: 34585591
  17. 17

    Value of upfront coronary computed tomography angiography in patients with non-ST-segment elevation acute coronary syndrome.

    Lu ZF, Yin WH, Lu B

    The international journal of cardiovascular imaging 2025; (41(4)):733-742 doi:10.1007/s10554-025-03360-7.

    PMID: 40045073

This page is for informational purposes only and does not constitute medical advice. For NSTE-ACS, follow your hospital team's instructions and report any returning chest pain or shortness of breath immediately.

Get notified when new evidence is published on intermediate coronary syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.